معرفی
Mark C. McMills is an Associate Professor in the Department of Chemistry and Biochemistry within the College of Arts and Sciences at Ohio University. His research is centered on synthetic organic chemistry with a focus on developing antitumor agents and advancing synthetic methodologies.
His research interests include synthetic organic chemistry, antitumor drug development, metallocarbenoid intermediates, ylide chemistry, and the total synthesis of complex natural products such as Taxol, Colchicine, Phorbol, Ingenol, and Quinocarcin. He also explores computational chemistry and furan-based cyclizations to construct biologically relevant scaffolds.
The recent publications highlight a strong emphasis on developing novel cyclization strategies, intramolecular reactions, and methodologies for carbon-carbon and carbon-heteroatom bond formation. His work bridges fundamental organic synthesis with applications in medicinal chemistry and drug discovery.
Dr. McMills earned his Ph.D. from Michigan State University and has contributed significantly to the field through innovative synthetic routes and mechanistic insights.
He has not received any explicitly mentioned scientific awards in the provided text.
Dr. McMills advises students in organic chemistry research, though specific names are not listed. His lab focuses on synthetic methodology and natural product synthesis, contributing to both academic knowledge and potential therapeutic applications. No external grants are mentioned in the provided content.
The research group explores areas such as azacycle formation, furan cyclizations, and the use of metallocarbenoids in constructing complex molecular architectures.
